• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Susac综合征(视网膜-耳蜗-脑脊髓血管炎),眼科医生作为举报人所起的作用。

Susac syndrome (Retino-cochleo-cerebral vasculitis), the ophthalmologist in the role of the whistleblower.

作者信息

Papasavvas Ioannis, Teuchner Barbara, Herbort Carl Peter

机构信息

Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Clinic Montchoisi Teaching Centre, Lausanne, Switzerland.

Department of Ophthalmology, University of Innsbruck, Innsbruck, Austria.

出版信息

J Ophthalmic Inflamm Infect. 2020 Oct 30;10(1):27. doi: 10.1186/s12348-020-00217-z.

DOI:10.1186/s12348-020-00217-z
PMID:33125601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7599291/
Abstract

BACKGROUND/PURPOSE: Susac syndrome is a rare microangiopathy of suspected autoimmune origin affecting arteries of the retina, the cochlea and the brain. The aim of the study was to give a review of the disease entity and determine the proportion of cases and their characteristics in a uveitis referral centre.

PATIENTS AND METHODS

Charts of patients with the diagnosis of Susac syndrome seen in the Uveitis Clinic of the Centre for Ophthalmic Specialised Care (COS), Lausanne, Switzerland were reviewed retrospectively to determine the frequency of such cases in a uveitis referral centre. Clinical symptoms and signs, functional data, imaging signs and evolution were analysed in the 3 COS cases and one case shared with the Uveitis Clinic of the Department of Ophthalmology, University of Innsbruck, Austria. Characteristic signs were searched possibly allowing a prompt diagnosis.

RESULTS

During the period from 1994 to 2019 (24 years, 2045 patients), 3 charts with the diagnosis of Susac syndrome were found (0.15%). The whole collective, including the additional case, comprised three women aged 28, 32 and 63 at presentation and one man, aged 42. None of the 3 cases that were referred were diagnosed beforehand. The characteristic item found in all 4 cases was the abrupt arterial stop or segmental interruption of arteries and increased staining of arterial wall on angiography more clearly shown on indocyanine green angiography that can potentially be proposed as a crucial diagnostic element. All 4 cases responded to dual steroidal and non-steroidal immunosuppression. Under treatment, all four patients did not show any further evolution.

CONCLUSION

Susac syndrome is a multilocation arteritis of the head that can involve the eye, ear and brain often first diagnosed by the ophthalmologist. The diagnosis is rapidly reached in uveitis referral centres but seems to be missed otherwise, A helpful angiographic sign to be searched is an abrupt or segmental arterial stop and increased staining of the arterial wall more clearly seen on indocyanine green angiography. Patients often present first to the ophthalmologist who should be acting as a whistleblower to avoid severe involvement of the brain.

摘要

背景/目的:Susac综合征是一种罕见的微血管病,怀疑起源于自身免疫,可累及视网膜、耳蜗和脑动脉。本研究的目的是对该疾病实体进行综述,并确定葡萄膜炎转诊中心的病例比例及其特征。

患者与方法

回顾性分析瑞士洛桑眼科专科护理中心(COS)葡萄膜炎诊所诊断为Susac综合征的患者病历,以确定葡萄膜炎转诊中心此类病例的发生率。对3例COS病例以及与奥地利因斯布鲁克大学眼科系葡萄膜炎诊所共享的1例病例的临床症状和体征、功能数据、影像学表现及病情进展进行了分析。寻找可能有助于快速诊断的特征性表现。

结果

在1994年至2019年期间(24年,共2045例患者),发现3例诊断为Susac综合征的病历(0.15%)。包括额外病例在内的全部病例中,有3名女性,就诊时年龄分别为28岁、32岁和63岁,1名男性,年龄为42岁。转诊的3例病例均未预先诊断。在所有4例病例中发现的特征性表现是动脉造影时动脉突然中断或节段性中断,以及动脉壁染色增强,吲哚菁绿血管造影更清晰地显示了这一点,这可能被视为关键的诊断要素。所有4例病例对甾体和非甾体联合免疫抑制治疗均有反应。治疗期间,所有4例患者均未出现进一步进展。

结论

Susac综合征是一种头部多部位动脉炎,可累及眼、耳和脑,通常由眼科医生首先诊断。在葡萄膜炎转诊中心可迅速做出诊断,但在其他情况下似乎易被漏诊。一个有用的血管造影表现是动脉突然或节段性中断,以及动脉壁染色增强,吲哚菁绿血管造影更清晰可见。患者通常首先就诊于眼科医生,眼科医生应发挥预警作用,以避免脑部严重受累。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/59e67914935b/12348_2020_217_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/318f3eacec9e/12348_2020_217_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/2f2bac4886b7/12348_2020_217_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/7aedb44faa6b/12348_2020_217_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/4cea9b75c1fe/12348_2020_217_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/cc43f6fc66f2/12348_2020_217_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/ed1e3acdfca7/12348_2020_217_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/60fa8ea67e00/12348_2020_217_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/ce6f5e2f39c7/12348_2020_217_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/058d06fc642e/12348_2020_217_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/99f147515797/12348_2020_217_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/253ee2e794b2/12348_2020_217_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/10b89bb7663a/12348_2020_217_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/84cf6670f2dc/12348_2020_217_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/2b5c217252f6/12348_2020_217_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/59e67914935b/12348_2020_217_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/318f3eacec9e/12348_2020_217_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/2f2bac4886b7/12348_2020_217_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/7aedb44faa6b/12348_2020_217_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/4cea9b75c1fe/12348_2020_217_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/cc43f6fc66f2/12348_2020_217_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/ed1e3acdfca7/12348_2020_217_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/60fa8ea67e00/12348_2020_217_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/ce6f5e2f39c7/12348_2020_217_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/058d06fc642e/12348_2020_217_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/99f147515797/12348_2020_217_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/253ee2e794b2/12348_2020_217_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/10b89bb7663a/12348_2020_217_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/84cf6670f2dc/12348_2020_217_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/2b5c217252f6/12348_2020_217_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/7599291/59e67914935b/12348_2020_217_Fig15_HTML.jpg

相似文献

1
Susac syndrome (Retino-cochleo-cerebral vasculitis), the ophthalmologist in the role of the whistleblower.Susac综合征(视网膜-耳蜗-脑脊髓血管炎),眼科医生作为举报人所起的作用。
J Ophthalmic Inflamm Infect. 2020 Oct 30;10(1):27. doi: 10.1186/s12348-020-00217-z.
2
Fluorescein and indocyanine green angiographies in Susac syndrome.Susac综合征中的荧光素和吲哚菁绿血管造影术。
Retina. 2007 Nov-Dec;27(9):1238-42. doi: 10.1097/IAE.0b013e31809ff824.
3
Susac syndrome: microangiopathy of the retina, cochlea and brain.Susac综合征:视网膜、耳蜗和脑的微血管病。
Clin Exp Ophthalmol. 2000 Oct;28(5):373-81. doi: 10.1046/j.1442-9071.2000.00345.x.
4
[Susac syndrome - an unusual syndrome which can be mistaken for multiple sclerosis].苏萨克综合征——一种可能被误诊为多发性硬化症的罕见综合征
Lakartidningen. 2020 Feb 10;117:FSSS.
5
[Update on Susac syndrome].[Susac综合征的最新进展]
Rev Med Interne. 2022 Jan;43(1):26-30. doi: 10.1016/j.revmed.2021.05.014. Epub 2021 Jun 9.
6
Immunosuppressive agents or intravenous immunoglobulin in addition to glucocorticoids in the treatment of Susac syndrome: a French national cohort study.除糖皮质激素外,免疫抑制剂或静脉注射免疫球蛋白治疗Susac综合征:一项法国全国队列研究。
Lancet Rheumatol. 2025 Jan;7(1):e15-e20. doi: 10.1016/S2665-9913(24)00220-0. Epub 2024 Sep 18.
7
Susac syndrome.苏萨克综合征
Otol Neurotol. 2004 Jul;25(4):470-3. doi: 10.1097/00129492-200407000-00012.
8
A brief review of Susac syndrome.Susac 综合征简述。
J Neurol Sci. 2012 Nov 15;322(1-2):35-40. doi: 10.1016/j.jns.2012.05.021. Epub 2012 May 27.
9
Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature.脑、视网膜和耳蜗微血管病变(苏萨克综合征)。5例报告及文献复习
Ophthalmology. 1998 Jun;105(6):1038-44. doi: 10.1016/S0161-6420(98)96005-5.
10
Review of Susac syndrome.综述:苏珊综合征
Curr Opin Ophthalmol. 2011 Nov;22(6):472-6. doi: 10.1097/ICU.0b013e32834bbfeb.

引用本文的文献

1
Successful treatment of a complete Susac syndrome in a 16-year-old boy: A case report.一名16岁男孩完全型Susac综合征的成功治疗:病例报告
Clin Case Rep. 2024 Jul 24;12(8):e9027. doi: 10.1002/ccr3.9027. eCollection 2024 Aug.
2
Incomplete Susac's Syndrome: A Case Report and Literature Review.不完全性苏萨克综合征:一例报告及文献综述
Cureus. 2022 Aug 11;14(8):e27903. doi: 10.7759/cureus.27903. eCollection 2022 Aug.
3
Characteristics and management of Susac syndrome in an emergent country: a multi-center case series from Brazil.

本文引用的文献

1
Susac's syndrome: an update.苏萨克斯综合征:更新。
Br J Ophthalmol. 2020 Sep;104(9):1190-1195. doi: 10.1136/bjophthalmol-2019-315597. Epub 2020 Feb 6.
2
CD8 T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome.CD8 T 细胞介导的血管内皮病是 Susac 综合征神经炎症的一个可靶向的机制。
Nat Commun. 2019 Dec 18;10(1):5779. doi: 10.1038/s41467-019-13593-5.
3
EVALUATION OF TUMOR NECROSIS FACTOR INHIBITOR THERAPY IN SUSAC SYNDROME.评估肿瘤坏死因子抑制剂疗法在 SUSAC 综合征中的应用。
紧急状态国家中 Susac 综合征的特征和治疗:来自巴西的多中心病例系列。
Neurol Sci. 2022 Nov;43(11):6449-6460. doi: 10.1007/s10072-022-06320-4. Epub 2022 Aug 9.
4
Susac Syndrome: A Rare cause of Bilateral Sensorineural hearing loss from North India-A Case Report with Review of literature.苏萨克综合征:印度北部双侧感音神经性听力损失的罕见病因——病例报告并文献复习
Indian J Otolaryngol Head Neck Surg. 2022 Jun;74(2):196-204. doi: 10.1007/s12070-021-02853-w. Epub 2021 Sep 16.
Retina. 2020 Mar;40(3):581-590. doi: 10.1097/IAE.0000000000002466.
4
Susac's syndrome: isolated retinal artery occlusion after 10 years of remission.苏萨克综合征:缓解10年后出现孤立性视网膜动脉阻塞。
Arq Bras Oftalmol. 2018 Apr;81(2):144-147. doi: 10.5935/0004-2749.20180031.
5
Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography.光谱域光学相干断层扫描检测到的 Susac 综合征的视网膜病变。
Neurology. 2015 Aug 18;85(7):610-8. doi: 10.1212/WNL.0000000000001852. Epub 2015 Jul 22.
6
Distinguishing Susac's syndrome from multiple sclerosis.鉴别Susac综合征与多发性硬化症。
J Neurol. 2015 Jul;262(7):1613-21. doi: 10.1007/s00415-014-7628-9. Epub 2014 Dec 30.
7
Susac's syndrome--pathogenesis, clinical variants and treatment approaches.苏萨克斯综合征——发病机制、临床变异型和治疗方法。
Autoimmun Rev. 2014 Aug;13(8):814-21. doi: 10.1016/j.autrev.2014.04.004. Epub 2014 Apr 12.
8
Update on Susac syndrome: new insights in brain and retinal imaging and treatment options.苏萨克综合征的最新进展:脑和视网膜成像及治疗选择的新见解
J Alzheimers Dis. 2014;42 Suppl 3:S99-108. doi: 10.3233/JAD-132519.
9
Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.Susac 综合征的临床、辅助检查和血清学表现:一项国际多中心研究。
J Neuroinflammation. 2014 Mar 8;11:46. doi: 10.1186/1742-2094-11-46.
10
Susac syndrome treated with subcutaneous immunoglobulin.采用皮下免疫球蛋白治疗 Susac 综合征。
Eur Neurol. 2014;71(1-2):89-92. doi: 10.1159/000354181. Epub 2013 Dec 5.